avasimibe has been researched along with Malignant Melanoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, Y; Chang, CC; Chang, TY; Chen, S; Li, BL; Li, L; Liu, W; Liu, X; Meng, X; Song, BL; Sun, SC; Wang, J; Wang, L; Xiong, Y; Xu, C; Yan, C; Yang, W; Zhang, J; Zhang, T; Zheng, X; Zhou, P | 1 |
1 other study(ies) available for avasimibe and Malignant Melanoma
Article | Year |
---|---|
Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism.
Topics: Acetamides; Acetates; Acetyl-CoA C-Acetyltransferase; Animals; Atherosclerosis; CD8-Positive T-Lymphocytes; Cell Membrane; Cholesterol; Esterification; Female; Immunological Synapses; Immunotherapy; Male; Melanoma; Mice; Programmed Cell Death 1 Receptor; Receptors, Antigen, T-Cell; Signal Transduction; Sulfonamides; Sulfonic Acids | 2016 |